VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemiaSteven Sher, Rosa Lapalombella|Leukemia|2022Cited by 37
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformationZachary A. Hing, Rosa Lapalombella|Nature Communications|2023Cited by 32
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemiaJanani Ravikrishnan, Deepa Sampath, Elizabeth M. Muhowski et al.|Haematologica|2024Cited by 12
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemiaJanek S. Walker, Rosa Lapalombella|Nature Communications|2021Cited by 9